Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / United Kingdom

GSK Signs Drug Discovery Deal With ChemoCentryx

August 2006 | Company News Alert

UK firm GlaxoSmithKline (GSK) has entered into a drug discovery collaboration with US biotech company ChemoCentryx in the field of chemokines that could net ChemoCentryx up to a staggering US$1.5bn in research funding and milestone payments.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Versamed Acquisition Sees GE Healthcare Further Penetrate Respiratory Market

Companies / United Kingdom UK based GE Healthcare has recently announced the acquisition of portable-ventilator maker Versamed Medical Systems, as it look to expand its product portfolio in respiratory care management. Talks between...
March 2008
NHS Prescribing More Obesity Drugs

Industry / United Kingdom The number of prescriptions for obesity drugs in the UK's National Health Service (NHS) has increased more than eight times since 1999 as the prevalence of the debilitating condition grow and doctors...
March 2008
NHS Prescribing More Obesity Drugs

Industry / United Kingdom The number of prescriptions for obesity drugs in the UK's National Health Service (NHS) has increased more than eight times since 1999 as the prevalence of the debilitating condition grow and doctors...
March 2008
GSK Acquires US Consumer Health Firm CNS

Companies / United Kingdom In an effort to expand its product offering and remain competitive with the major players, UK firm GlaxoSmithKline (GSK) has revealed that it is to acquire US consumer healthcare company CNS for $566mn....
October 2006
Shire, Barr Settle ADHD Drug Dispute

Companies / United Kingdom Ensuring greater future revenues and causing its share price to increase, Shire Pharmaceuticals - the UK's third largest drugmaker - has settled its dispute with US-based Barr Pharmaceuticals over generic...
August 2006
Western Europe InsightWestern Europe Channels Western Europe Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS